Rohto Pharmaceutical Co.,Ltd.
RPHCF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.89B
Close$
$39.36
128.9% upside
Current Fair Value
128.9% upsideUndervalued by 128.9% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3.89 Billion |
|---|---|
| Enterprise Value | $-22,591,477,652.00 |
| Annual dividend | $0.32 |
| Dividend yield | 1.82% |
| Earnings per Share | $151.79 |
| Beta | -0.44 |
| Outstanding Shares | 225,964,000 |
Return
| Return on Equity | 10.80% |
|---|---|
| Return on Assets | 6.86% |
| Return on Invested Capital | 11.38% |
Valuation & Multiples
| P/E Ratio | 18.69 |
|---|---|
| PEG | -176.53 |
| Price to Sales | 0.01 |
| Price to Book Ratio | 0.01 |
| Enterprise Value to Revenue | 1.67 |
| Enterprise Value to EBIT | 13.84 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.19 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$0.25
Consensus analyst estimateRevenue Estimate
$535.29 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$0.21
Consensus analyst estimateRevenue Estimate
$567.37 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Rohto Pharmaceutical Co.,Ltd.
9,292 employees
CEO: Hidetoshi Segi
Established in Osaka, Japan, in 1899, Rohto Pharmaceutical Co.,Ltd. is a global entity engaged in the development, manufacturing, and marketing of a diverse array of pharmaceutical goods, beauty products, and nutritional supplements. The...